Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PRV-6527
PRV-6527
After midstage flop, Janssen says thanks but no thanks to Provention Bio drug
Fierce Biotech
Fri, 01/3/20 - 10:02 am
Janssen
Provention Bio
Crohn’s disease
PRV-6527
JNJ
Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study
Endpoints
Wed, 10/23/19 - 10:12 am
Provention Bio
JNJ
Crohn's Disease
clinical trials
PRV-6527
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
Endpoints
Thu, 09/21/17 - 08:49 am
JNJ
Provention Bio
IBD
inflammatory bowel disease
PRV-6527
Crohn's Disease
PRV-300
ulcerative colitis